 David Anderson
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Venous Thromboembolism | 11 | 2022 | 324 | 2.290 |
Why?
| | Aspirin | 4 | 2018 | 385 | 1.190 |
Why?
| | Arthroplasty, Replacement, Hip | 3 | 2018 | 179 | 1.120 |
Why?
| | Platelet Aggregation Inhibitors | 4 | 2018 | 469 | 1.120 |
Why?
| | Anticoagulants | 10 | 2022 | 667 | 1.010 |
Why?
| | Dalteparin | 2 | 2013 | 10 | 0.820 |
Why?
| | Hematology | 2 | 2020 | 19 | 0.800 |
Why?
| | Venous Thrombosis | 5 | 2020 | 190 | 0.560 |
Why?
| | Surgical Procedures, Operative | 1 | 2019 | 266 | 0.510 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 170 | 0.500 |
Why?
| | Rivaroxaban | 1 | 2018 | 256 | 0.480 |
Why?
| | Pulmonary Embolism | 4 | 2020 | 235 | 0.420 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2018 | 366 | 0.390 |
Why?
| | Postoperative Complications | 2 | 2021 | 2722 | 0.310 |
Why?
| | Warfarin | 2 | 2008 | 153 | 0.280 |
Why?
| | Thrombophilia | 2 | 2022 | 87 | 0.260 |
Why?
| | Hemorrhage | 3 | 2022 | 747 | 0.200 |
Why?
| | Catheterization, Central Venous | 1 | 2005 | 113 | 0.200 |
Why?
| | Myocardial Ischemia | 1 | 2024 | 278 | 0.190 |
Why?
| | Postthrombotic Syndrome | 2 | 2013 | 13 | 0.180 |
Why?
| | Double-Blind Method | 4 | 2018 | 1949 | 0.170 |
Why?
| | History, 21st Century | 1 | 2019 | 214 | 0.150 |
Why?
| | Models, Statistical | 1 | 2021 | 663 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1567 | 0.130 |
Why?
| | Risk Factors | 7 | 2022 | 10252 | 0.130 |
Why?
| | Ticlopidine | 1 | 2015 | 52 | 0.110 |
Why?
| | Dyspnea | 1 | 2016 | 255 | 0.110 |
Why?
| | Exercise Tolerance | 1 | 2016 | 278 | 0.110 |
Why?
| | Humans | 19 | 2024 | 138651 | 0.110 |
Why?
| | Stockings, Compression | 1 | 2013 | 5 | 0.110 |
Why?
| | Intermittent Claudication | 1 | 2015 | 122 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2016 | 710 | 0.100 |
Why?
| | Activities of Daily Living | 1 | 2016 | 421 | 0.100 |
Why?
| | Middle Aged | 9 | 2018 | 33604 | 0.100 |
Why?
| | Recurrence | 4 | 2021 | 1084 | 0.100 |
Why?
| | Male | 11 | 2024 | 68260 | 0.090 |
Why?
| | Aged | 8 | 2021 | 24024 | 0.090 |
Why?
| | Ischemia | 1 | 2015 | 414 | 0.090 |
Why?
| | Health Status | 1 | 2016 | 819 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 768 | 0.090 |
Why?
| | Hospitalization | 1 | 2019 | 2235 | 0.080 |
Why?
| | Neoplasms | 2 | 2020 | 2681 | 0.080 |
Why?
| | Patient Selection | 1 | 2013 | 676 | 0.080 |
Why?
| | Adult | 9 | 2022 | 38201 | 0.070 |
Why?
| | Peripheral Arterial Disease | 1 | 2015 | 486 | 0.070 |
Why?
| | Canada | 3 | 2016 | 407 | 0.070 |
Why?
| | Factor V | 2 | 2022 | 24 | 0.070 |
Why?
| | United States | 3 | 2020 | 14938 | 0.070 |
Why?
| | Female | 10 | 2021 | 73763 | 0.070 |
Why?
| | Physical Examination | 1 | 2008 | 238 | 0.060 |
Why?
| | Predictive Value of Tests | 3 | 2020 | 2030 | 0.060 |
Why?
| | Prospective Studies | 4 | 2022 | 7554 | 0.060 |
Why?
| | Placebos | 1 | 2005 | 198 | 0.060 |
Why?
| | Quality of Life | 1 | 2016 | 2954 | 0.050 |
Why?
| | Catheters, Indwelling | 1 | 2005 | 90 | 0.050 |
Why?
| | Cohort Studies | 3 | 2021 | 5697 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2024 | 56 | 0.050 |
Why?
| | Prothrombin | 1 | 2022 | 26 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2053 | 0.050 |
Why?
| | Radiography | 1 | 2005 | 841 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2015 | 10923 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2015 | 7677 | 0.040 |
Why?
| | Electrocardiography | 1 | 2024 | 612 | 0.040 |
Why?
| | Contraceptive Agents | 1 | 2021 | 66 | 0.040 |
Why?
| | Trust | 1 | 2021 | 144 | 0.040 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2020 | 91 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1482 | 0.040 |
Why?
| | Probability | 1 | 2020 | 308 | 0.040 |
Why?
| | Neurosurgical Procedures | 1 | 2020 | 204 | 0.040 |
Why?
| | Perfusion Imaging | 1 | 2016 | 62 | 0.030 |
Why?
| | Walk Test | 1 | 2016 | 80 | 0.030 |
Why?
| | Ultrasonography | 1 | 2020 | 745 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2020 | 745 | 0.030 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 131 | 0.030 |
Why?
| | Platelet Function Tests | 1 | 2015 | 29 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1057 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2015 | 520 | 0.030 |
Why?
| | Echocardiography | 1 | 2016 | 640 | 0.030 |
Why?
| | Exercise Test | 1 | 2016 | 622 | 0.030 |
Why?
| | California | 1 | 2015 | 436 | 0.030 |
Why?
| | Propensity Score | 1 | 2015 | 316 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2851 | 0.020 |
Why?
| | Point-of-Care Systems | 1 | 2015 | 184 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 896 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1032 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3433 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1229 | 0.020 |
Why?
| | Mutation | 1 | 2022 | 3987 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2016 | 1109 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1235 | 0.020 |
Why?
| | Critical Illness | 1 | 2015 | 831 | 0.020 |
Why?
| | Health Status Indicators | 1 | 2008 | 163 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2016 | 5112 | 0.020 |
Why?
| | Observer Variation | 1 | 2008 | 350 | 0.020 |
Why?
| | Incidence | 1 | 2013 | 2747 | 0.020 |
Why?
| | Registries | 1 | 2015 | 2073 | 0.020 |
Why?
| | Adolescent | 1 | 2005 | 21564 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 6851 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2049 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3307 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2339 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 5803 | 0.010 |
Why?
|
|
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|